Efficacy of different anticoagulant doses for patients with COVID-19: a systematic review and network meta-analysis

PURPOSE: As no reported randomized control trials (RCTs) directly compare the three administration doses of anticoagulants (prophylactic dose, treatment dose, and no treatment), the most recommended dose to be administered to patients with coronavirus disease 2019 (COVID-19) remains unclear. The pur...

Descripción completa

Detalles Bibliográficos
Autores principales: Yasuda, Hideto, Mayumi, Takuya, Okano, Hiromu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966866/
https://www.ncbi.nlm.nih.gov/pubmed/35355236
http://dx.doi.org/10.1007/s15010-022-01809-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966866/
https://www.ncbi.nlm.nih.gov/pubmed/35355236
http://dx.doi.org/10.1007/s15010-022-01809-8

Ejemplares similares